Shounak Roy

Title: Shounak Roy: Innovator in Immune Response Modulation

Introduction

Shounak Roy is a notable inventor based in Jadavpur, India. He has made significant contributions to the field of immunology through his innovative research and patenting efforts. His work focuses on the modulation of immune responses, particularly through the inhibition of toll-like receptor signaling.

Latest Patents

Shounak Roy holds a patent for a groundbreaking invention titled "Blocking toll-like receptor 9 signaling with small molecule antagonist." This invention relates to small molecule 4-(piperazin-1-yl)quinazolin-2-amino compounds, which are useful for inhibiting signaling by certain toll-like receptors, especially TLR9. Toll-like receptors are critical components of the immune system, playing a vital role in distinguishing self from non-self. Aberrant activation of TLR9 is linked to various autoimmune diseases, making this invention particularly relevant for therapeutic applications. The compounds described in the patent can be utilized in clinical settings as pharmaceutical agents to treat conditions associated with unwanted immune activity due to TLR9 activation.

Career Highlights

Shounak Roy is affiliated with the Council of Scientific & Industrial Research, where he continues to advance his research in immunology. His work has garnered attention for its potential impact on treating autoimmune diseases and improving immune response management.

Collaborations

Shounak collaborates with esteemed colleagues, including Arindam Talukdar and Dipyaman Ganguly, who contribute to his research endeavors and enhance the scope of his projects.

Conclusion

Shounak Roy's innovative work in the field of immunology, particularly through his patent on TLR9 signaling inhibition, showcases his commitment to advancing medical science. His contributions have the potential to lead to significant advancements in the treatment of autoimmune diseases.